News
The small molecule, vatiquinone, had already flunked a Phase III trial, but the company pushed ahead with an approval bid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback